Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2024-06-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
提名人声明与承诺（缪嘉军）
Regulatory Filings Classification · 95% confidence The document is a formal statement and commitment regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The document is a regulatory announcement related to board management and nomination but does not announce a change in board members or senior management itself. It is not a full report or financial filing but a compliance and nomination statement. Given the nature of the content, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-06-06 Chinese
董事会薪酬与考核委员会工作细则（2024年6月）
Governance Information Classification · 100% confidence The document is titled as the "薪酬与考核委员会工作细则" (Remuneration and Assessment Committee Working Rules) of the 葵花药业集团股份有限公司 (Kwaihua Pharmaceutical Group Co., Ltd.). It details the structure, responsibilities, composition, and procedures of the company's remuneration and assessment committee, which is a governance-related document. It references relevant laws and company bylaws, and focuses on the committee's role in reviewing and proposing remuneration policies for directors and senior management. There is no financial data, no report of financial results, no voting results, no announcement of a report, nor any other regulatory filing or transaction. This document fits the definition of a Governance Information report, which details the company's internal rules, board structure, and governance practices. The document length is under 5,000 characters, but it is a substantive governance document, not a mere announcement. Therefore, the correct classification is Governance Information (CGR).
2024-06-06 Chinese
董事会审计委员会工作细则（2024年6月）
Governance Information Classification · 95% confidence The document is titled as the 'Audit Committee Working Rules' of the Board of Directors of a company. It details the structure, responsibilities, meeting rules, and operational procedures of the Audit Committee. It does not contain financial statements, audit opinions, or results of audits, but rather governance and procedural guidelines related to audit oversight. It is not an audit report itself, nor an annual or interim report. It is a governance-related document focused on the audit committee's role and internal control oversight. Therefore, the most appropriate classification is 'Governance Information' (CGR). The document length is 2709 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full financial report.
2024-06-06 Chinese
信息披露管理制度（2024年6月）
Governance Information Classification · 95% confidence The document is titled as an "Information Disclosure Management System" for a company, detailing comprehensive internal policies, procedures, and responsibilities related to information disclosure. It extensively references regulatory requirements, disclosure principles, types of reports (annual, interim, quarterly, temporary), and internal controls. It does not contain actual financial data, earnings, or audit results, nor is it a transcript or announcement of a specific event. Instead, it is a governance and compliance document outlining the company's information disclosure framework and management system. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-06-06 Chinese
股东大会议事规则（2024年6月）
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of a company, detailing the governance, procedures, and regulations for conducting shareholders' meetings. It includes sections on the convocation, proposals, attendance, voting, resolutions, meeting records, and post-meeting matters. It is a governance-related document outlining internal rules and practices for shareholder meetings rather than a report of financial results, announcements, or meeting minutes. It does not contain financial data, voting results, or announcements of meetings but rather the procedural framework for such meetings. Therefore, it fits best under Governance Information (CGR). The document length (9215 characters) and content confirm it is a full governance rules document, not a brief announcement or a report publication notice.
2024-06-06 Chinese
关于修改公司《章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding amendments to the company's Articles of Association (公司章程). It includes extensive legal and regulatory references, detailed provisions about shareholder rights, board responsibilities, capital structure, and governance rules. The content is focused on corporate governance, shareholder meeting procedures, and internal company rules rather than financial results or audit opinions. There is no indication that this is a full annual report, audit report, earnings release, or any other financial statement. It is not a brief announcement or a voting result declaration but a comprehensive governance document. Therefore, the document fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-06-06 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.